Metaplanet
3350
Nippon Telegraph & Telephone
9432
Toyota Motor
7203
4
Mitsubishi
8058
5
SoftBank
9434
JP Stock MarketDetailed Quotes
4893 Noile-Immune Biotech
- 168
- -8-4.55%
20min DelayMarket Closed Feb 28 15:30 JST
7.27BMarket Cap-6.17P/E (Static)
174High168Low215.60KVolume172Open176Pre Close36.60MTurnover35352wk High1.61%Turnover Ratio43.30MShares12152wk Low-22.01EPS TTM2.24BFloat Cap775Historical HighLossP/E (Static)13.36MShs Float121Historical Low-27.25EPS LYR3.41%Amplitude--Dividend TTM1.45P/B100Lot Size--Div YieldTTM
Noile-Immune Biotech News
Noil Immune --- For the fiscal year ending December 2024, the in-house drug development business and the joint pipeline will continue to be promoted.
Noil Immune Biotech <4893> announced its financial results for the fiscal year ending December 2024 on the 14th. Business revenue was 0.007 billion yen (compared to 0.316 billion yen in the previous term), operating loss was 1.069 billion yen (compared to a loss of 0.775 billion yen in the previous term), recurring loss was 0.962 billion yen (compared to a loss of 1.127 billion yen in the previous term), and net loss for the year was 0.964 billion yen (compared to a loss of 1.13 billion yen in the previous term). As for the company's business status for the fiscal year, the self-developed drug discovery business based on PRIME technology and the joint pipeline will continue.
Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Kirin HD, Matsukiyo Cocok, Dentsu Group, Rakuten Group (14th) (1379-5368)
The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- February 14 (Friday) <1379> Hokuto <1380> Akigawa Boku-en <1417> Mirait-Wan <142A> Jinjibu <1438> Gifu Landscaping <1443> Giken HD <1447> SAAF HD <145A> Elizbee<
Noile Immune ETC [Stocks with appeal viewed from Volume changes]
Stock closing prices compared to the previous day, Volume * <2814> Sato Foods 21102155600 * <4893> Noile Immune 195215296000 * <5724> Asaka Riken 85826206900 * <7859> Almedio 339576372700 * <6864> NF HD 1529229920900 * <1443> Giken HD 1905262600 * <6366> Chiyo Construction 337376659200 * <5074> Tes Holdings 289354
Individual stock information.
EF Code <9211.T> continues to rise significantly. It will become a consolidated subsidiary of Ciel Zero, an IT engineering service company based in Osaka. In the future, Ciel Zero will utilize its engineering expertise, experience, IT personnel, and development resources to further expand its business. GATECH <3491.T> drops significantly, declining for three consecutive days. In the overseas market, mainly in Europe and Asia (excluding the USA and Canada), there will be a public offering of 4,072,400 new shares.
Emerging Markets Stock Digest: GA TECH has fallen significantly for three consecutive days, and HENNGE has hit the upper limit.
＜4592＞ SanBio 767 +25 significantly rebounding. The financial estimates for the January 2025 period have been revised upward from a previous forecast of a 3.359 billion yen deficit to a 2.736 billion yen deficit (compared to the prior period's performance of a 2.644 billion yen deficit). The year-end Exchange Rates have been confirmed, and the amount related to foreign currency loans and related claims against consolidated subsidiaries is expected to result in an exchange gain of approximately 0.623 billion yen, leading to a reduction in the deficit. The operating profit and loss forecast indicates a 3.339 billion yen deficit (compared to the same period's 4.539 billion yen deficit.
Volume change rate ranking (14:00) ~ Almedio, Noyl Immune, ETC are ranked.
By comparing the average Volume over the last five days with the Volume on the day of distribution, the ranking of the Volume change rate can reveal trends in stock selection and the interests of market participants. ■ Top of the Volume Change Rate [As of February 5, 14:32] (Comparison of the Average Volume over the Last Five Days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <4893> Noile Immuno 14452800 53150 0.94367.48% 0.0362% <7859
Volume change rate ranking (9 AM slot) - F-Code, HENNGE, ETC ranked.
In the ranking of Volume change rate, by comparing the average Volume of the last 5 days with the Volume on the day of delivery, you can understand the trends in stock selection and the interests of market participants. ■ Top Volume change rates [As of February 5, 9:32] (Comparison of the past 5 days average Volume) Stock Code Stock Name Volume 5 Day Average Volume Volume Change Rate Stock Price Change Rate <4893> Noile Immune 5910600107185.08328.89%0.1554%<3747>
<Today's individual materials> Noil Bio, Sankuzer, Yamada Securities, NTN, ETC (announced on the 4th)
▽ Noil Bio <4893.T>, concluded a Single Option contract with the University of Tokyo for nucleic acid delivery polymer compounds. ▽ Sankyu <2937.T>, revised upward the consolidated performance Financial Estimates for the fiscal year ending March 25. ▽ Yamada Soken <4351.T>, revised downward the consolidated performance Financial Estimates for the fiscal year ending December 24. ▽ NTN <6472.T>, the consolidated financial results for the third quarter of the fiscal year ending March 25 (April to December 24) turned to a final loss. ▽ Kawasaki Kisen <9107.T>, the consolidated results for the third quarter of the fiscal year ending March 25 (April to December) are...
Sankuzeuru, Noil Immune and others.
＜2937＞ Sankuzer revised upward, this period's operating profit estimate is 0.782 billion yen ← 0.611 billion yen. <3491> GA TECH is issuing new Stocks due to overseas recruitment (4.07 million shares). <3908> Colabo's off-market sales, 0.17 million shares performance estimate revision, this period's operating profit estimate is 0.074 billion yen ← 0.07 billion yen. <4592> San Bio performance estimate revision, this period's ordinary profit estimate is △2.736 billion yen ← △3.359 billion yen. <4893> Noil Immune National Universities Corporation The University of Tokyo and nucleic acid transfer.
Emerging Markets outlook: The Growth Market 250 Index ETF failed to break through the 200-day moving average, and the market may continue to lack direction.
■Weak movements due to expectations of a policy interest rate hike; this week, Emerging Markets declined. During the same period, the Nikkei Average fell by -1.89%, while the Growth Market Index dropped by -2.75% and the Growth Market 250 Index decreased by -2.93%, showing weakness compared to the Nikkei Average. The Growth Market 250 Index was expected to break through the resistance of the 200-day moving average (200MA), but it failed, worsening investor sentiment. Trading volume showed no significant changes, remaining in the 100 billion yen range, as the policy interest rate was influenced by the Bank of Japan.
Stocks with peculiar taste from volume change, such as Modaris, etc.
Closing price of stocks compared to the previous day, Volume * <7371> Zenken 5,062,298,000 * <4736> Japan Rad 860,150,448,000 * <3858> Ubi AI 497,742,828,500 * <4883> Modalis 109,728,896,000 * <4885> Muromachi Chemical 981,503,002,00 * <9439> MH Group 1,952,143,900 * <4893> Noile Immun 182,121,460,600 * <9204> Skymark 602,372,521.
Noil Immune Biotech --- Selection of loan stocks in the Tokyo Stock Exchange Growth Market.
Noil Immune Biotech <4893> announced on the 20th that it has been selected as a borrowable stock in the Tokyo Stock Exchange's Growth Market. The company is an academia-origin biotech firm working on the practical application of next-generation cancer immunotherapy for solid tumors using its unique innovative technology, "PRIME technology," which enhances the therapeutic effects of immune cell therapy through PRIME CAR-T cells. The selection date is December 23, 2024 (Monday), and the implementation will start from the trading of that day.
Noil Immune, True Data, among others.
Revised financial estimates: forecasted consolidated ordinary profit for the first half is 0.013 billion yen, down from 0.027 billion yen, and the full-year consolidated ordinary profit forecast is 0.101 billion yen, down from 0.136 billion yen.
Noile-Immune Biotech: Notice regarding publication of earnings forecasts
Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
Asahi, Matsukiyo, Dentsu Group, Lancers (14th) (1379-4990)
※The above calendar is merely a schedule and may be subject to change due to the company's circumstances. --------------------------------------- November 14 (Thursday) <1379> Hokuto <1380> Akikawa Bokuen <142A> Jinjibu <1438> Gifu Landscape <1443> Giken HD <1446> Candiule <1447> SAAF HD <145A> El
Volume change rate ranking (10:00 am) - NEC, KIMOTO, etc. are ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in trading by comparing the average volume of the past 5 days with the volume on the delivery day. ■ Top volume change rate [10:32 on October 30] (comparison of average volume of the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜7908＞KIMOTO 59854 0118 210.44 282% 0.2663% ＜4893＞NOI
Noile-Immune Biotech: Correction Confirmation Form
Noile-Immune Biotech: Revised Semi-Annual Report - Term 10 (2024/01/01 to 2024/12/31)